217 related articles for article (PubMed ID: 32921677)
1. Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function.
Shinohara M; Wada R; Yano K; Akitsu K; Koike H; Kinoshita T; Suzuki T; Fujino T; Ikeda T
Int Heart J; 2020 Sep; 61(5):944-950. PubMed ID: 32921677
[TBL] [Abstract][Full Text] [Related]
2. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
Nagai R; Kinugawa K; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
Circ J; 2013; 77(4):908-16. PubMed ID: 23502991
[TBL] [Abstract][Full Text] [Related]
3. Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study.
Kinugawa K; Nagai R; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
Adv Ther; 2014 Apr; 31(4):426-39. PubMed ID: 24643403
[TBL] [Abstract][Full Text] [Related]
4. Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction.
Oka E; Iwasaki YK; Maru E; Fujimoto Y; Ito-Hagiwara K; Hayashi H; Yamamoto T; Yodogawa K; Hayashi M; Shimizu W
Circ J; 2019 Mar; 83(4):793-800. PubMed ID: 30814430
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.
Sezai A; Osaka S; Yaoita H; Ishii Y; Arimoto M; Hata H; Shiono M
J Thorac Cardiovasc Surg; 2015 Oct; 150(4):957-64. PubMed ID: 26254752
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery.
Nishi H; Sakaguchi T; Miyagawa S; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Kuratani T; Sawa Y
Heart Vessels; 2013 Jul; 28(4):490-6. PubMed ID: 22661097
[TBL] [Abstract][Full Text] [Related]
7. Addition of a β1-Blocker to Milrinone Treatment Improves Cardiac Function in Patients with Acute Heart Failure and Rapid Atrial Fibrillation.
Kobayashi S; Myoren T; Kajii T; Kohno M; Nanno T; Ishiguchi H; Nishimura S; Fukuda M; Hino A; Fujimura T; Ono M; Uchinoumi H; Tateishi H; Mochizuki M; Oda T; Okuda S; Yoshiga Y; Kawano R; Yano M
Cardiology; 2019; 142(4):195-202. PubMed ID: 31137022
[TBL] [Abstract][Full Text] [Related]
8. Landiolol: A Review in Tachyarrhythmias.
Syed YY
Drugs; 2018 Mar; 78(3):377-388. PubMed ID: 29470800
[TBL] [Abstract][Full Text] [Related]
9. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
Sumitomo N; Horigome H; Miura M; Ono H; Ueda H; Takigiku K; Yoshimoto J; Ohashi N; Suzuki T; Sagawa K; Ushinohama H; Takahashi K; Miyazaki A; Sakaguchi H; Iwamoto M; Takamuro M; Tokunaga C; Nagano T;
J Cardiol; 2017 Sep; 70(3):232-237. PubMed ID: 28073682
[TBL] [Abstract][Full Text] [Related]
10. Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy.
Niwa Y; Koike M; Iwata N; Kobayashi D; Tanaka C; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Hepatogastroenterology; 2014 Sep; 61(134):1546-51. PubMed ID: 25436340
[TBL] [Abstract][Full Text] [Related]
11. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I
J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Kakihana Y; Nishida O; Taniguchi T; Okajima M; Morimatsu H; Ogura H; Yamada Y; Nagano T; Morishima E; Matsuda N;
Lancet Respir Med; 2020 Sep; 8(9):863-872. PubMed ID: 32243865
[TBL] [Abstract][Full Text] [Related]
13. An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension.
Nitta D; Kinugawa K; Imamura T; Endo M; Amiya E; Inaba T; Maki H; Hatano M; Komuro I
Int Heart J; 2015; 56(5):564-7. PubMed ID: 26370372
[TBL] [Abstract][Full Text] [Related]
14. Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial.
Sohns C; Zintl K; Zhao Y; Dagher L; Andresen D; Siebels J; Wegscheider K; Sehner S; Boersma L; Merkely B; Pokushalov E; Sanders P; Schunkert H; Bänsch D; Mahnkopf C; Brachmann J; Marrouche NF
Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008461. PubMed ID: 32903044
[TBL] [Abstract][Full Text] [Related]
15. Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
Adachi T; Sato A; Baba M; Hiraya D; Hasegawa T; Kuroki K; Hoshi T; Aonuma K
Heart Vessels; 2014 Jul; 29(4):464-9. PubMed ID: 23801459
[TBL] [Abstract][Full Text] [Related]
16. A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Yamashita T; Nakasu Y; Mizutani H; Sumitani K
J Cardiol; 2019 Nov; 74(5):418-425. PubMed ID: 31255463
[TBL] [Abstract][Full Text] [Related]
17. Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Yamashita T; Saitoh T; Matsushita M
J Cardiol; 2015 Jul; 66(1):69-72. PubMed ID: 25454208
[TBL] [Abstract][Full Text] [Related]
18. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X
J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501
[TBL] [Abstract][Full Text] [Related]
19. [Perioperative heart rate control with landiolol for a patient with rapid atrial fibrillation complicated with low cardiac function].
Sakai H; Igarashi K; Imai M; Miura K; Kanai M; Okazaki A
Masui; 2004 May; 53(5):555-8. PubMed ID: 15198243
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery.
Sakaguchi M; Sasaki Y; Hirai H; Hosono M; Nakahira A; Seo H; Suehiro S
Int Heart J; 2012; 53(6):359-63. PubMed ID: 23258136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
